Sökning: id:"swepub:oai:DiVA.org:uu-104290" >
Renal dysfunction a...
Renal dysfunction as a risk factor for mortality and cardiovascular disease in renal transplantation : experience from the Assessment of Lescol in Renal Transplantation trial
-
- Fellström, Bengt, 1947- (författare)
- Uppsala universitet,Institutionen för medicinska vetenskaper,Njurmedicin, The ALERT trial
-
- Jardine, Alan G. (författare)
- The ALERT Trial
-
- Soveri, Inga (författare)
- Uppsala universitet,Institutionen för medicinska vetenskaper,Njurmedicin, The ALERT Trial
-
visa fler...
-
- Cole, Edward (författare)
- The ALERT Trial
-
- Grönhagen-Riska, Carola (författare)
- The ALERT Trial
-
- Neumayer, Hans H. (författare)
- The ALERT Trial
-
- Maes, Bart (författare)
- The ALERT Trial
-
- Gimpelewicz, Claudio (författare)
- The ALERT Trial
-
- Holdaas, Hallvard (författare)
- The ALERT Trial
-
visa färre...
-
(creator_code:org_t)
- Lippincott, Williams and Wilkins, 2005
- 2005
- Engelska.
-
Ingår i: Transplantation. - : Lippincott, Williams and Wilkins. - 0041-1337 .- 1534-6080. ; 79:9, s. 1160-1163
- Relaterad länk:
-
https://urn.kb.se/re...
Abstract
Ämnesord
Stäng
- BACKGROUND: Renal-transplant recipients have shortened life expectancy primarily because of premature cardiovascular disease. Traditional and nontraditional risk factors for cardiovascular disease are prevalent in renal patients. In renal-transplant recipients, immunosuppressive therapy can be nephrotoxic and aggravate cardiovascular disease risk factors. Renal dysfunction has been established as a risk factor for cardiovascular disease and mortality in different populations. We evaluated the effects of baseline renal-transplant function on mortality and cardiovascular and renal endpoints in 1,052 placebo-treated patients of the Assessment of Lescol in Renal Transplantation trial. METHODS: All renal-transplant recipients were on cyclosporine-based immunosuppressive therapy. Follow-up was 5 to 6 years, and endpoints included cardiac death, noncardiovascular death, all-cause mortality, major adverse cardiac event (MACE), stroke, nonfatal myocardial infarction, and graft loss. RESULTS: Baseline serum creatinine was strongly and independently associated with increased cardiac, noncardiovascular, and all-cause mortality, as well as MACE and graft loss. Serum creatinine was not a risk factor for stroke or nonfatal myocardial infarction. CONCLUSIONS: Elevated baseline serum creatinine in renal-transplant recipients is a strong and independent risk factor for all-cause, noncardiovascular and cardiac mortality, MACE, and graft loss.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Urologi och njurmedicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Urology and Nephrology (hsv//eng)
Nyckelord
- Renal transplant function
- Risk factor
- Mortality
- Cardiovascular disease
- Kidney diseases
- Njursjukdomar
- Medicin
- Medicine
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas